Journal of Critical Care
Volume 26, Issue 3 , Pages 330.e9-330.e12, June 2011

Protein C as an early biomarker to distinguish pneumonia from sepsis

  • Scott Gutovitz, MD

      Affiliations

    • Department of Emergency Medicine, University of Kansas Hospital, Kansas City, KS 66160
    • Corresponding Author InformationCorresponding author. Department of Emergency Medicine, 3901 Rainbow Blvd, University of Kansas Hospital, Kansas City, KS 66160, USA.
  • ,
  • Linda Papa, MD

      Affiliations

    • Department of Emergency Medicine, Orlando Health, Orlando, FL 32806
  • ,
  • Edgar Jimenez, MD

      Affiliations

    • Department of Emergency Medicine, Orlando Health, Orlando, FL 32806
  • ,
  • Jay Falk, MD

      Affiliations

    • Department of Emergency Medicine, Orlando Health, Orlando, FL 32806
  • ,
  • Leighann Wieman, MD

      Affiliations

    • Department of Emergency Medicine, Orlando Health, Orlando, FL 32806
  • ,
  • Sandra Sawyer, BA

      Affiliations

    • Department of Emergency Medicine, Orlando Health, Orlando, FL 32806
  • ,
  • Philip Giordano, MD

      Affiliations

    • Department of Emergency Medicine, Orlando Health, Orlando, FL 32806

published online 02 September 2010.

Abstract 

Purpose

Patients with pneumonia often are unrecognized as also having sepsis. We evaluated protein C, as a potential biomarker, to differentiate between patients with pneumonia and sepsis.

Materials and Methods

A retrospective chart review was performed for all protein C tests over a 14-month period (January 11, 2007, to March 10, 2008) at an 8-hospital system with 1706 total beds. Charts were screened for the discharge diagnoses of sepsis, severe sepsis, septic shock, bacteremia, and pneumonia. Protein C levels were compared between patients with sepsis and pneumonia, and at time intervals of 0 to 12 hours, 12 to 24 hours, 24 to 48 hours, and more than 48 hours after diagnosis.

Results

One thousand forty-seven protein C levels were obtained in 980 patients. Thirty-two protein C levels met the inclusion and exclusion criteria for the sepsis group, and 34 for the pneumonia group. Overall, the mean protein C levels were significantly less in patients with sepsis at 59.2% (95% confidence interval [CI], 49.5%-68.9%) compared with patients with pneumonia at 108.9% (95% CI, 95.6%-122.3%; P < .001). In addition, levels within each of the time intervals were also significantly lower in the sepsis group.

Conclusions

In this study, protein C levels performed well in differentiating between patients with sepsis or pneumonia in the early period after diagnosis.

Keywords: Pneumonia, Sepsis, Biomarkers, Protein C

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest: None of the listed authors have any personal or financial conflicts of interest to disclose in this study.

PII: S0883-9441(10)00178-4

doi:10.1016/j.jcrc.2010.07.002

Journal of Critical Care
Volume 26, Issue 3 , Pages 330.e9-330.e12, June 2011